EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, iRhythm Technologies's enterprise value is $3,619.5 Mil.
iRhythm Technologies's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $492.7 Mil. Therefore, iRhythm Technologies's EV-to-Revenue for today is 7.35.
The historical rank and industry rank for iRhythm Technologies's EV-to-Revenue or its related term are showing as below:
IRTC'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.82 Med: 10.81 Max: 29.02
Current: 7.35
During the past 10 years, the highest EV-to-Revenue of iRhythm Technologies was 29.02. The lowest was 3.82. And the median was 10.81.
IRTC's EV-to-Revenue is ranked worse than 76.46% of 824
companies
in the Medical Devices & Instruments industry
Industry Median: 3.04
vs IRTC: 7.35
iRhythm Technologies EV-to-Revenue Historical Data
The historical data trend for iRhythm Technologies's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of iRhythm Technologies's EV-to-Revenue
For the Medical Devices subindustry, iRhythm Technologies's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Technologies's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where iRhythm Technologies's EV-to-Revenue falls into.
iRhythm Technologies's current Enterprise Value is $3,619.5 Mil.
iRhythm Technologies's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $492.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRhythm Technologies's share price for today is $111.27.
iRhythm Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $16.14.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRhythm Technologies EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of iRhythm Technologies's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
iRhythm Technologies (iRhythm Technologies) Business Description
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio include ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for up to 14 consecutive days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IRTC has been successfully added to your 